APA (7th ed.) Citation

Le Roux, Ö., Everitt, J. I., & Counter, C. M. (2024). p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis. PLoS ONE, 19(3), 1. https://doi.org/10.1371/journal.pone.0292189

Chicago Style (17th ed.) Citation

Le Roux, Özgün, Jeffery I. Everitt, and Christopher M. Counter. "P53 Dosage Can Impede KrasG12D- and KrasQ61R-mediated Tumorigenesis." PLoS ONE 19, no. 3 (2024): 1. https://doi.org/10.1371/journal.pone.0292189.

MLA (9th ed.) Citation

Le Roux, Özgün, et al. "P53 Dosage Can Impede KrasG12D- and KrasQ61R-mediated Tumorigenesis." PLoS ONE, vol. 19, no. 3, 2024, p. 1, https://doi.org/10.1371/journal.pone.0292189.